Background and literature

• Patent filed: WO2020221937A1
• Anti-GA efficacy in cellular models:
  https://www.embopress.org/doi/full/10.15252/emmm.201607054 (open access)
  https://www.embopress.org/doi/full/10.15252/embj.2019102811 (open access)
• Anti-GA efficacy in mice:
  https://www.embopress.org/doi/full/10.15252/emmm.201910919 (open access)

Publications resulting from the project (open access)

• Development and Preclinical Evaluation of a Copper-64-Labeled Antibody Targeting Glycine-Alanine Dipeptides for PET Imaging of C9orf72-Associated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
  Monireh Shojaei, Qihui Zhou, Giovanna Palumbo, Rebecca Schaefer, Janne Kaskinoro, Pirjo Vehmaan-Kreula, Peter Bartenstein, Matthias Brendel, Dieter Edbauer, and Simon Lindner
  ACS Pharmacology & Translational Science 2024 7 (5), 1404-1414
  DOI: 10.1021/acsptsci.4c00037